跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,906 条关于
“GPR52 agonist”
全部
5,906
临床试验
3,229
药物
796
机构
5
资讯
1,876
9个月前
Nxera Pharma Regains Rights to Phase 2-Ready Schizophrenia Drug After Boehringer Ingelheim Declines Licensing Option
去年
Boehringer Ingelheim Expands Schizophrenia Pipeline with Sosei Heptares and Autifony Collaborations
10个月前
Nxera Pharma Announces Strategic Restructuring with 15% Workforce Reduction to Focus on GPCR Pipeline
去年
Schizophrenia Clinical Trial Pipeline Boasts 60+ Drugs Under Development
28天前
Orphan GPCR GPR52 Governs Collective Invasion and Multicellular Organization in Breast Cancer
去年
AstraZeneca Presents Promising Early Data on Oral GLP-1 Agonist AZD5004 and Amylin Agonist AZD6234 for Obesity Treatment
去年
Researchers Identify Anti-Mouse PD-1 Agonist Antibodies That Inhibit T Cell Activation
去年
Novo Nordisk Enters Agreement with Ascendis Pharma for Monthly GLP-1 Agonist
去年
Palatin Technologies Completes Enrollment in Phase 2 Obesity Trial of Bremelanotide and Tirzepatide Combination
去年
Palatin Technologies Completes Enrollment in Phase 2 Obesity Trial of Bremelanotide with Tirzepatide
第 1 页,共 188 页
上一页
下一页